- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
73 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALAArovella Therapeutics | AU$0.04 | -7.0% | -11.1% | AU$26.8m | n/a | PS40.8x | E-7.5% | n/a | ||
| MVPMedical Developments International | AU$3.64 | -3.7% | -39.2% | AU$259.5m | AU$4.75 | PS11.6x | E53.2% | 0% | ||
| PIQProteomics International Laboratories | AU$1.11 | -0.9% | -18.1% | AU$116.8m | n/a | PS42x | n/a | n/a | ||
| CPHCreso Pharma | AU$0.064 | -4.5% | -68.8% | AU$83.0m | n/a | PS13.4x | n/a | n/a | ||
| BOTBotanix Pharmaceuticals | AU$0.083 | 1.2% | -5.7% | AU$80.8m | n/a | PB5.6x | n/a | n/a | ||
| PYCPYC Therapeutics | AU$0.10 | 5.3% | -39.4% | AU$318.1m | n/a | PS35.1x | n/a | n/a | ||
| CUVClinuvel Pharmaceuticals | AU$17.54 | 1.8% | -41.7% | AU$866.7m | AU$27.57 | PE35.9x | E29.4% | 0.1% | ||
| CSLCSL | AU$264.95 | -0.2% | -1.2% | AU$127.6b | AU$305.81 | PE40.6x | E14.4% | 1.1% | ||
| DXBDimerix | AU$0.16 | -8.6% | -37.3% | AU$51.3m | n/a | PS11.5x | n/a | n/a | ||
| PXSPharmaxis | AU$0.10 | 7.5% | 19.0% | AU$54.9m | n/a | PS3x | S2.7% | n/a | ||
| ATHAlterity Therapeutics | AU$0.019 | 0% | -38.7% | AU$45.7m | n/a | PS9.5x | n/a | n/a | ||
| LCTLiving Cell Technologies | AU$0.008 | 14.3% | -38.5% | AU$8.2m | n/a | PS53.3x | n/a | n/a | ||
| GSSGenetic Signatures | AU$1.34 | 1.9% | -9.5% | AU$192.0m | AU$1.38 | PE98x | E-90.2% | n/a | ||
| GTGGenetic Technologies | AU$0.004 | -20.0% | -50.0% | AU$36.9m | n/a | PS17.4x | n/a | n/a | ||
| NSBNeuroScientific Biopharmaceuticals | AU$0.28 | 1.8% | 12.0% | AU$40.2m | n/a | PS41.9x | n/a | n/a | ||
| VLSVita Life Sciences | AU$2.20 | -6.4% | 91.3% | AU$123.0m | n/a | PE14.8x | n/a | 2.7% | ||
| SPLStarpharma Holdings | AU$0.88 | -2.8% | -52.8% | AU$356.5m | n/a | PS104.2x | n/a | n/a | ||
| OPTOpthea | AU$1.02 | 1.0% | -30.6% | AU$359.0m | AU$1.65 | PB2.6x | E24.5% | n/a | ||
| IMMImmutep | AU$0.34 | -1.4% | -22.5% | AU$294.7m | AU$1.07 | PS78.9x | E75.4% | n/a | ||
| ADOAnteoTech | AU$0.12 | 4.5% | -62.3% | AU$228.5m | n/a | PS79.3x | n/a | n/a | ||
| PABPatrys | AU$0.024 | 9.1% | -11.1% | AU$49.4m | n/a | PS17.8x | n/a | n/a | ||
| IVXInvion | AU$0.015 | -3.2% | 66.7% | AU$96.2m | n/a | PS40.5x | n/a | n/a | ||
| ILAIsland Pharmaceuticals | AU$0.20 | -4.9% | -53.6% | AU$15.8m | n/a | PB2.7x | n/a | n/a | ||
| AC8AusCann Group Holdings | AU$0.067 | -4.3% | -50.4% | AU$29.5m | n/a | PS14.5x | n/a | n/a |